BCV
EVLO

Banque Cantonale Vaudoise’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-125
Closed -$18K – 1415
2021
Q3 		$18K Hold
125
– – ﹤0.01% 1174
2021
Q2 		$34K Hold
125
– – ﹤0.01% 1099
2021
Q1 		$27K Hold
125
– – ﹤0.01% 1056
2020
Q4 		$30K Hold
125
– – ﹤0.01% 985
2020
Q3 		$13K Buy
+125
New +$11.4K ﹤0.01% 1000

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Banque Cantonale Vaudoise's EVLO Position: Q4 2021 in Review

Banque Cantonale Vaudoise sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2021, closing a stake of 125 shares — an estimated $18K sold.

Banque Cantonale Vaudoise first reported a position in EVLO in Q3 2020 and held it in 5 quarters. The position peaked at $34K in Q2 2021. 66 funds tracked by Wall St. Rank hold EVLO as of Q4 2021.

  • Banque Cantonale Vaudoise reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 125 Evelo Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $18K.
  • Banque Cantonale Vaudoise first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Banque Cantonale Vaudoise's Evelo Biosciences, Inc. Common Stock position peaked at $34K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2021, filed 14 Feb 2022.